文献速递前列腺癌

优化磁共振成像引导下靶向与系统经会阴前列腺穿刺活检的针数

Optimising the number of cores for magnetic resonance imaging-guided targeted and systematic transperineal prostate biopsy.
PubMed 文献 · BJU Int · 2019-08-01

单中心前瞻性研究纳入487例具有单一靶向磁共振病变的男性,行经会阴磁共振/超声融合引导活检,比较两针靶向活检、四针扩展靶向活检、10–20针饱和靶向活检及14针同侧靶向活检与联合靶向加系统活检对Gleason评分≥7前列腺癌的检出率。

要点

  • 两针靶向活检检出67%的Gleason评分7–10癌,四针扩展靶向活检76%,饱和靶向活检与同侧靶向活检均为91%。
  • 饱和靶向活检较两针靶向活检多检出25%的Gleason评分7–10癌男性,仅需10–20针。
  • 在前列腺体积≤45 mL且前部高可疑病变>0.5 mL的33例亚组中,四针扩展靶向活检检出32例中的31例癌及全部26例Gleason评分7–10癌。

核心结论

  • 饱和靶向活检较两针靶向活检多检出25%的Gleason评分7–10癌男性,检出率接近20–26针联合靶向加系统活检的91%,而仅需10–20针。
  • 对于前列腺体积小或轻度增大的前部大体积高可疑病变,四针扩展靶向活检可能足够。

研究设计与样本

  • 单中心前瞻性收集2012年至2016年间487例具有单一靶向磁共振成像病变男性的经会阴磁共振/超声融合引导活检结局。

主要发现

  • 345例男性检出癌症,211例检出Gleason评分7–10癌。
  • 两针靶向活检检出67%的Gleason评分7–10癌,四针扩展靶向活检76%,饱和靶向活检91%,同侧靶向活检91%。
  • 在33例(占队列7%)前部>0.5 mL高可疑磁共振病变且前列腺体积≤45 mL的亚组中,四针扩展靶向活检检出32例中的31例癌症(97%)及全部26例Gleason评分7–10癌。

关键数值与推荐

  • 所有男性行两针靶向活检后,按Ginsburg方案行18–24针系统分区活检。
  • 饱和靶向活检包括靶向区域及邻近区域,共10–20针。
  • 同侧靶向活检共14针。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To assess cancer detection rates of different target-dependent transperineal magnetic resonance (MR)/ultrasonography (US) fusion-guided biopsy templates with reduced number of systematic cores. PATIENTS AND METHODS: Single-centre outcome of transperineal MR/US fusion-guided biopsies of 487 men with a single target MR imaging (MRI) lesion, prospectively collected between 2012 and 2016. All men underwent transperineal targeted biopsy (TB) with two cores, followed by 18-24 systematic sector biopsies (SB) using the Ginsburg protocol. Gleason score ≥7 prostate cancer detection rates for two-core TB, four-core extended TB (eTB), 10- to 20-core saturation TB (sTB) including cores from sectors adjacent to the target, and 14 core ipsilateral TB (iTB) were compared to combined TB+SB. RESULTS: Cancer was detected in 345 men and Gleason score 7-10 cancer in 211 men. TB alone detected 67%, eTB 76%, sTB 91% and iTB 91% of these Gleason score 7-10 cancers. In the subgroup of 33 men (7% of cohort) with an anterior >0.5 mL highly suspicious MRI lesion and a prostate volume ≤45 mL, four-core eTB detected 31 of 32 cancers (97%) and all 26 Gleason score 7-10 cancers. CONCLUSION: sTB detected Gleason score 7-10 cancer in 25% more of the men than a two-core TB approach, and in almost as many men (91%) as the 20-26-core combined TB+SB, while needing only 10-20 cores. A four-core extended TB may suffice for large, highly suspicious anterior lesions in small or slightly enlarged prostates.

来源:BJU Int,查看原文。版权归原作者所有。

引用

  1. Hansen NL, Barrett T, Lloyd T, et al. Optimising the number of cores for magnetic resonance imaging-guided targeted and systematic transperineal prostate biopsy. BJU Int. 2019. PMID: 31306539. doi:10.1111/bju.14865

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。